KRAS gene mutations in lung cancer: particulars established and issues unresolved.
about
New and emerging factors in tumorigenesis: an overviewPermissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activityCapturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.Proteome analysis for downstream targets of oncogenic KRAS--the potential participation of CLIC4 in carcinogenesis in the lung.Allelic imbalance in the miR-31 host gene locus in lung cancer--its potential role in carcinogenesis.Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung CancerUp-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression.A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironment.Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications.Expression of HDAC9 in lung cancer--potential role in lung carcinogenesis.Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies.Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases.Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion.Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patienNew syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.Outcome analysis of Phase I trial patients with metastatic and/or mutant non-small cell lung cancer
P2860
Q26801253-9949438B-BDB2-465D-9F67-9953CA7354D9Q33743847-0C883DFF-AD58-4A46-94AD-3C95EEC1A84AQ34104005-1CAAB8F3-BC5A-4B76-A98C-C292B407F1DCQ35087713-2EB01DE3-A7A8-4E51-A5EE-2A204CE7F3B6Q35198062-E41D0FFA-F73B-4AD4-9B3B-E0DA7FB5820EQ35967703-5A6EEBEF-7DF1-4741-8CA5-69375843AAC1Q36257504-0069727C-2EF5-4042-A548-20CBC5363497Q36865033-5F84BC9E-D9E3-4F6D-B3CD-4897E123C804Q37061020-01C3F14A-2BC5-489F-A9BB-34CF0D95D119Q37603357-642D5D27-52A5-492D-9FBE-CC7148878EBAQ38682370-EFFC5662-2617-401C-8061-84BB5A4B916DQ39034218-85A02439-86D2-44F6-9FAE-6481A4C2D911Q43748644-03F5DF4A-82C9-4324-83DB-58ABE2747F9AQ45019855-B767D099-0507-423B-AAC9-E0E41E0B3C81Q47161252-7432C10F-4136-43C9-8ED9-FCE277C7D7AAQ47164556-E2FE5A88-640B-4736-A2DF-A03AD7F04C7AQ53243017-A93B22C8-FED5-46EE-8C6B-DBD54E3F1995Q57117154-6D0DC9DC-C6D8-40F8-BB2B-F3C1F0E789EA
P2860
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
@en
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
@nl
type
label
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
@en
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
@nl
prefLabel
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
@en
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
@nl
P2093
P2860
P1476
KRAS gene mutations in lung cancer: particulars established and issues unresolved.
@en
P2093
Hitoshi Kitamura
Koji Okudela
Tetsukan Woo
P2860
P304
P356
10.1111/J.1440-1827.2010.02580.X
P577
2010-10-01T00:00:00Z